Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)
Go back to Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 17.85 +0.13 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.72 | 52 Week High | $19.75 | |||
| Open | $17.74 | 52 Week Low | $4.26 | |||
| Day High | $17.87 | P/E | N/A | |||
| Day Low | $17.31 | EPS | $0.00 | |||
| Volume | 13,060,178 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.11 -0.56 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.67 | 52 Week High | $63.73 | |||
| Open | $20.63 | 52 Week Low | $8.00 | |||
| Day High | $20.74 | P/E | N/A | |||
| Day Low | $19.62 | EPS | $-5.69 | |||
| Volume | 6,292,416 | |||||
